RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/g8ggWUGPFl, see more https://t.co/DYNr6PkPQa
RT @tsalazargr: - Sólo un 5% de los españoles tiene ya anticuerpos del covid19 - El porcentaje es mayor en el centro de la península - Un 3…
RT @Demostenes_eu: Parece que hay veces que hacemos las cosas bien. Un poco tarde, pero bien
The primary article is linked here: https://t.co/aWCSDH9Yft
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @RebuiRosa: Indispensable seguir cuidándose. Mascarilla. 2 mts de distancia. Lavarse las manos con jabón por 20 segundos. Si no tiene qu…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @_AlexArenas: Estamos casi en la casilla de salida. Toda precaución es poca👇
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @RaquelYotti: El estudio #ENECOVID se acaba de publicar en la prestigiosa revista @TheLancet. Una muestra del reconocimiento científico…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
So that should put paid to anyone entertaining a herd immunity approach. #noherdimmunity #noantibodies https://t.co/O2dYmd9wY6
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @PCMagalhaes: Se querem saber o que acho que mais nos faz falta é isto, um estudo destes, mesmo que de menor escala. Se não fizemos aind…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @_MiguelHernan: Spain's seroprevalence study #ENECOVID is out @TheLancet #SARSCoV2 IgG antibodies: 5% nationwide, 11% in Madrid Lower…
"La mayoría de los casos confirmados por PCR tienen AC detectables, pero una proporción sustancial de personas con síntomas compatibles con #COVID19 no se sometieron a una prueba de PCR y al menos 1/3 de las infecciones determinadas por serología fueron as
"In light of these findings, any proposed approach to achieve herd immunity through natural infection is not only highly unethical, but also unachievable. With a large majority of the population being infection naive, virus circulation can quickly return"
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
- Sólo un 5% de los españoles tiene ya anticuerpos del covid19 - El porcentaje es mayor en el centro de la península - Un 33% de los infectados son asintomáticos, pero contagiosos! https://t.co/7dwpA5nWJg
RT @IlindelatorreMD: 5% de la población española tiene anticuerpos. https://t.co/XLSkeng2nc
RT @JA_PerezMolina: Very informative and detailed article on the serprevalence of COVID-19 in Spain. This is the result of a hugh coordinat…
RT @_MiguelHernan: Spain's seroprevalence study #ENECOVID is out @TheLancet #SARSCoV2 IgG antibodies: 5% nationwide, 11% in Madrid Lower…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @Laurie_Garrett: Hotspots of #COVID19 in Spain have <10% population antibody levels. So: "In light of these findings, any proposed appro…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
Well well well, turns out that herd immunity is impossible, even with a vaccine. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/k2XKiBJZdE
RT @antonello: Esto lo hemos hecho muy bien. Hasta donde he leído/indagado sobre el asunto, primer país en publicar un estudio de seropreva…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @RaquelYotti: Los resultados de la primera ronda de #ENECOVID se acaban de publicar en una de las revistas científica más importantes de…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @RaquelYotti: El estudio #ENECOVID se acaba de publicar en la prestigiosa revista @TheLancet. Una muestra del reconocimiento científico…
RT @pinabertoglia: Estudio SARS-CoV-2 España confirma baja seroprevalencia: 5% nacional, 11% Madrid. Claramente insuficiente para inmunidad…
2/2 Lancet paper here https://t.co/esolseVra9
RT @pmarsupia: El estudio de seroprevalencia en España acaba de ser publicado en The Lancet, una de las revistas científicas más prestigios…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @alexandraphelan: Spain's SARS-CoV-2 prevalence is just ~5% despite one of Europe's largest #covid19 epidemics, from study today in @The…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @Rogufe: Un estudio de referencia mundial... Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiol…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
5% seroprevalence in ~61000 participants, of which a 3rd of #COVID19 infections were #ASYMPTOMATIC in #Spain highlights the continued need for #public #health measures to avoid new wave of the epidemic https://t.co/11lGafNHBr
RT @BeatrizPerezGom: @natasufe @sanidadgob @apolidura @pimase81 @Lamamadenpol Aquí tenéis el artículo que cuenta la primera oleada https://…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @mjgrech: Si algo se ha hecho bien, pues se dice 👇 https://t.co/qAOuDzgIaH
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
Interesting graphics from a Spanish study, regions with % of immunity in the population (Max 14%, I've read we'll need at least 70% for 'Herd Immunity'). Just to confirm this is bad news for now, but good to see these studies with large sample sizes. Discl
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @kikollan: El estudio de prevalencia que hizo España es fantástico. Apenas existen otros a nivel nacional y —lo más importante— con una…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @devisridhar: My take-away is that antibodies may not be best way to track % of people exposed given they seem to fade after COVID in le…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @TheLancet: NEW—First nationwide population-based study presents seroprevalence estimates of antibodies against SARS-CoV-2 at national a…
RT @Laurie_Garrett: Hotspots of #COVID19 in Spain have <10% population antibody levels. So: "In light of these findings, any proposed appro…
RT @bajoelbillete: Sí, vale, sé que siempre estoy criticando cosas, pero para variar tengo que admitir que el estudio de seroprevalencia qu…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
@WhiteHouse @realDonaldTrump More bad news... https://t.co/hxd88MwrLf
RT @astro_duque: Proud of Spain's researchers for carrying out this ambitious nationwide seroprevalence study, published today in the prest…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
RT @ashishkjha: New paper out in @TheLancet about seroprevalence of COVID antibodies in Spain. Here's the paper: https://t.co/ZidtTyKsei…
RT @_MiguelHernan: Spain's seroprevalence study #ENECOVID is out @TheLancet #SARSCoV2 IgG antibodies: 5% nationwide, 11% in Madrid Lower…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
Spanish Seroprevalence = 5%...